LD0638.0A

General

Cell Line

hPSCreg name CHOPi005-A
Cite as:
CHOPi005-A (RRID:CVCL_B3NQ)
Alternative name(s)
LD0638.0A
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
INSRMi019-A
(PC129K8)
Donor diseases:
myofibrillar myopathy 1
INSRMi020-A
(PC130k2c)
Donor diseases:
myofibrillar myopathy 1
CUIMCi005-A
(BB#2, BB9068#2)
Donor diseases:
Stargardt Disease
FJMUUHi001-A
Donor's gene variants:
PARK7
Donor diseases:
Parkinson's disease 7
SCTCi014-A
(IPS17-00056)
Donor diseases:
Age-Related Macular Degeneration
SCTCi012-A
(IPS19-00027)
Donor diseases:
age-related macular degeneration
SCTCi013-A
(IPS19-00053)
Donor diseases:
age-related macular degeneration
USFi001-A
(1CN1.5)
Donor diseases:
Friedreich Ataxia
INSRMi012-C
(PC173T19)
Donor diseases:
myofibrillar myopathy 1
INSRMi013-A
(PC179c1)
Donor diseases:
myofibrillar myopathy 1
NIHTVBi022-A
(HT964)
Donor diseases:
Leukodystrophy
HEBHMUi012-A
Donor diseases:
Hypertension
BBANTWi010-A
(iPSC_PBMC_LDS_TGFB3_KE2M_C9)
Donor diseases:
Loeys-Dietz syndrome 5
SHEHi002-A
(iPS36)
Donor's gene variants:
CACNA1C
Donor diseases:
Long QT Syndrome 8
BIHi002-A
Donor's gene variants:
CLCN7, CLCN7
Donor diseases:
autosomal recessive osteopetrosis 4
PCIi027-A
(PC086)
Donor diseases:
Waardenburg syndrome
USPi001-A
(iPS_LGH_AHDC1_P1)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
LZUSHi001-A
(ips98)
Donor diseases:
Generalized Epilepsy
USPi002-A
(iPS_LGH_AHDC1_P2)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
USPi003-A
(iPS_LGH_AHDC1_P3)
Donor's gene variants:
AHDC1
Donor diseases:
Xia-Gibbs Syndrome
IGIBi001-A
(SCP28)
Donor diseases:
Sickle cell anemia
KMUGMCi006-A
(TS271 #12 WT)
Donor diseases:
Tuberous Sclerosis
CMCi002-A
(CMC-GIT-001)
Donor diseases:
Gitelman Syndrome
KMUGMCi006-B
(TS271 #5 MT)
Donor diseases:
Tuberous Sclerosis
HEBHMUi008-A
Donor's gene variants:
APOE
Donor diseases:
cerebrovascular disease
KMUGMCi006-C
(TS271 #21 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-D
(TS271 #23 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-E
(TS271 #4 MT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-F
(TS271 #20 MT)
Donor diseases:
Tuberous Sclerosis
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
KSCBi006-A
(KNIH-OI001i-A)
Donor's gene variants:
COL1A1
Donor diseases:
osteogenesis imperfecta type 1
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
SCTCi011-A
(IPS18-00072)
Donor diseases:
age-related macular degeneration
UKKi034-A
(NP0079-A, NP0079-7B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi034-B
(NP0079-B, NP0079-15B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Familial long QT syndrome
UKKi034-C
(NP0079-C, NP0079-16H)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
Familial long QT syndrome
Last update 13th August 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator The Children's Hospital of Philadelphia (CHOP)

External Databases

BioSamples SAMEA9693917
Cellosaurus CVCL_B3NQ
Wikidata Q110432716

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA9693918

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: vandervera@chop.edu
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? CHOP IRB
Approval number
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ 1

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Marker Present Absent
mCpG
OCT4 X
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Brachyury
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
OTX2
Unknown

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
NORMAL
Passage number: 16
Karyotyping method: G-Banding

Other Genotyping (Cell Line)